rs114402911
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_206933.4(USH2A):c.6240G>T(p.Lys2080Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00703 in 1,613,826 control chromosomes in the GnomAD database, including 61 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Another nucleotide change resulting in the same amino acid substitution has been previously reported as Likely benign in ClinVar.
Frequency
Consequence
NM_206933.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
USH2A | ENST00000307340.8 | c.6240G>T | p.Lys2080Asn | missense_variant | Exon 32 of 72 | 1 | NM_206933.4 | ENSP00000305941.3 | ||
USH2A | ENST00000674083.1 | c.6240G>T | p.Lys2080Asn | missense_variant | Exon 32 of 73 | ENSP00000501296.1 |
Frequencies
GnomAD3 genomes AF: 0.00730 AC: 1111AN: 152098Hom.: 9 Cov.: 32
GnomAD3 exomes AF: 0.00556 AC: 1396AN: 251140Hom.: 11 AF XY: 0.00520 AC XY: 705AN XY: 135706
GnomAD4 exome AF: 0.00700 AC: 10236AN: 1461610Hom.: 52 Cov.: 34 AF XY: 0.00680 AC XY: 4946AN XY: 727110
GnomAD4 genome AF: 0.00730 AC: 1111AN: 152216Hom.: 9 Cov.: 32 AF XY: 0.00708 AC XY: 527AN XY: 74428
ClinVar
Submissions by phenotype
not provided Benign:6
- -
This variant is associated with the following publications: (PMID: 25412400, 18273898) -
- -
- -
- -
USH2A: BP4, BS2 -
not specified Benign:5
- -
- -
Variant summary: USH2A c.6240G>T (p.Lys2080Asn) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0056 in 251140 control chromosomes, predominantly at a frequency of 0.01 within the African or African-American subpopulation in the gnomAD database, including 3 homozygotes. This frequency is almost close to that estimated for a pathogenic variant in USH2A causing Usher Syndrome (0.0056 vs 0.011), supporting a benign outcome. To our knowledge, no penetrant association of c.6240G>T in individuals affected with Usher Syndrome and no experimental evidence demonstrating its impact on protein function have been reported. Seven clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation and a predominant consensus as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign. -
- -
Lys2080Asn in Exon 32 of USH2A: This variant is not expected to have clinical si gnificance because it has been identified in 1.1% (41/3738) of African American chromosomes from a broad population by the NHLBI Exome Sequencing Project (http: //evs.gs.washington.edu/EVS; dbSNP rs114402911). As expected, this variant has b een reported in equal frequencies in cases and controls (Booij 2010, Clark 2010, Dreyer 2008, McGee 2010). -
Usher syndrome type 2A Benign:3
- -
- -
- -
Retinitis pigmentosa Uncertain:1
- -
Retinitis pigmentosa 39 Benign:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at